| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On September 22, 2026, Lakewood-Amedex Biotherapeutics Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the record date of July 30, 2026, there were 2,369,688 shares of Common Stock outstand... |
| 15 Jul 2026 | 8-K: Regulation FD Disclosure |
| 17 Jun 2026 | 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year |
| 28 Apr 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
Loading...
